arrow_back Back to App

Tardive Dyskinesia Awareness Week Designated to Highlight Medication Side Effects.

The Senate designated the first week of May 2023 as Tardive Dyskinesia Awareness Week to highlight this serious movement disorder affecting over 600,000 Americans. TD is often a side effect of long-term use of certain medications for mental health or gastrointestinal issues. The resolution aims to encourage better public understanding and improved screening practices by healthcare providers.
Key points
Official designation of an awareness week to increase public and medical community knowledge about Tardive Dyskinesia (TD).
TD is an involuntary movement disorder linked to common medications used for serious mental illnesses and stomach disorders.
The resolution encourages citizens to become better informed about TD risks and symptoms, potentially leading to earlier diagnosis.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_SRES_197
Sponsor: Sen. Mullin, Markwayne [R-OK]
Process start date: 2023-05-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating the week of May 1, 2023, through May 7, 2023, as "Tardive Dyskinesia Awareness Week".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_SRES_197.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-05-04.

What are the main provisions?

Key points include:

  • Official designation of an awareness week to increase public and medical community knowledge about Tardive Dyskinesia (TD).
  • TD is an involuntary movement disorder linked to common medications used for serious mental illnesses and stomach disorders.
  • The resolution encourages citizens to become better informed about TD risks and symptoms, potentially leading to earlier diagnosis.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Mullin, Markwayne [R-OK].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health